Oprah Winfrey is opening up about her experience using weight-loss drugs. The media mogul is sharing some of the realizations she has found after being under an undisclosed GLP-1, which is a type 2 ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

The risk of heart attack and stroke declines, but gastrointestinal problems and joint inflammation increase: New research has shed more light on the pros and cons of weight-loss jabs.

With every new year comes reflection and resolutions. But as we go to press well into January, it is worth a reminder that studies show nearly 90% ...